| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/12/2007 | WO2007011331A3 Water-soluble polymeric substrate having metallic nanoparticle coating |
| 04/12/2007 | WO2007009469A3 Potency assays for antibody drug substance binding to an fc receptor |
| 04/12/2007 | WO2007003399A3 Electrode assembly, use thereof, and method for the production thereof |
| 04/12/2007 | WO2007001737A3 Methods and compositions for detecting herpes simplex virus type 2 |
| 04/12/2007 | WO2007001398A9 Small molecule mediated biosensing using carbon nanotubes in homogeneous format |
| 04/12/2007 | WO2006138219A3 Methods of diagnosis / prognosis of inflammatory conditions |
| 04/12/2007 | WO2006136996A3 Apparatus for moving magnetic particles |
| 04/12/2007 | WO2006135775A3 Rapid saccharide biomarker assay |
| 04/12/2007 | WO2006133408A9 Breast cancer and prostate cancer assessment |
| 04/12/2007 | WO2006133016A3 Method for analyzing biological data sets |
| 04/12/2007 | WO2006129867A3 ENHANCED EXPRESSION OF LACTOFERRIN mRNA BY LACRITIN |
| 04/12/2007 | WO2006128740A3 Anti-vascular methods and therapies employing lysyl oxidase inhibitors |
| 04/12/2007 | WO2006128196A3 Novel substrate for rpn 11 enzymatic activity |
| 04/12/2007 | WO2006128026A3 Cellular receptor for varicella-zoster virus, methods of inhibiting spread of varicella-zoster and methods of increasing stability and infectivity of the virus |
| 04/12/2007 | WO2006128010A3 Quantification of nucleic acids and proteins using oligonucleotide mass tags |
| 04/12/2007 | WO2006126029A3 Malaria vaccines |
| 04/12/2007 | WO2006125222A3 Magnetically-responsive microparticles with improved response times |
| 04/12/2007 | WO2006124932A3 Kinase peptides and antibodies |
| 04/12/2007 | WO2006121869A3 Compositions and methods for treating mood and anxiety disorders |
| 04/12/2007 | WO2006119308A3 Method and apparatus for detecting analytes using an acoustic device |
| 04/12/2007 | WO2006116699A3 Method and system for absolute platelet percent aggregation determination |
| 04/12/2007 | WO2006110599A3 Cacna1e in cancer diagnosis, detection and treatment |
| 04/12/2007 | WO2006109277B1 Determination of partial fill in electrochemical strips |
| 04/12/2007 | WO2006108584A3 Human marker genes and agents for cardiovascular disorders and artherosclerosis |
| 04/12/2007 | WO2006108581A3 Human marker genes and agents for cardiovascular disorders and artherosclerosis |
| 04/12/2007 | WO2006107924A3 Ehrlichia canis diva (differentiate infected from vaccinated animals) |
| 04/12/2007 | WO2006094154A3 Methods and systems for designing animal food compositions |
| 04/12/2007 | WO2006091949A3 Phosphorylated p68 rna helicase as a marker for cancer and cancer metastasis |
| 04/12/2007 | WO2006089209A3 Txr1 and enhanced taxane sensitivity based on the modulation of a pathway mediated thereby |
| 04/12/2007 | WO2006089027A3 Lateral flow test kit and method for detecting an analyte |
| 04/12/2007 | WO2006085321A3 Compositions and methods for purifying and crystallizing molecules of interest |
| 04/12/2007 | WO2006083671B1 Bacterial glycolipid activation of cd1d-restricted nkt cells |
| 04/12/2007 | WO2006074430A3 Biomarkers for melanoma |
| 04/12/2007 | WO2006073504A3 Wobble sequencing |
| 04/12/2007 | WO2006073439A3 Surface enhanced spectroscpy-active composite nanop articles and their application in analysis and diagnosis |
| 04/12/2007 | WO2006071970A3 Methods for the detection of analytes in a sample |
| 04/12/2007 | WO2006065970A3 Systems and methods for predicting the lime requirements in soils |
| 04/12/2007 | WO2006062667A3 Sensor for determining concentration of ozone |
| 04/12/2007 | WO2006051551A3 Device and method for analysis of a metabolic malady |
| 04/12/2007 | WO2006048263A3 Gene expression profiling in acute promyelocytic leukemia |
| 04/12/2007 | WO2006041792A3 Analysis of metals in acidic solutions |
| 04/12/2007 | WO2006040534A3 Method of detecting the presence or activity of g - protein coupled receptor 92 (gpr92) |
| 04/12/2007 | WO2006032704A3 Diagnostic compounds for targeting a chemokine receptor |
| 04/12/2007 | WO2006023769A3 Determining data quality and/or segmental aneusomy using a computer system |
| 04/12/2007 | WO2006017473A3 Automated analysis of multiplexed probe-traget interaction patterns: pattern matching and allele identification |
| 04/12/2007 | WO2005113831A3 Biomarkers for multiple sclerosis and methods of use thereof |
| 04/12/2007 | WO2005107796A3 Cellular permissivity factor for viruses, and uses thereof |
| 04/12/2007 | WO2005106047A3 Detection of molecular interactions using colloid dispersion |
| 04/12/2007 | WO2005102019A3 Treatment of fluids and/or sludge with electro plasma |
| 04/12/2007 | WO2005060683A3 Small peptides for the treatment of alzheimer’s disease and other beta-amyloid protein fibrillogenesis disorders |
| 04/12/2007 | WO2005050171A3 Methods and compositions relating to single reactive center reagents |
| 04/12/2007 | WO2005014795A3 Osteoarthritis biomarkers and uses thereof |
| 04/12/2007 | WO2005005951A3 Fluidic force discrimination |
| 04/12/2007 | WO2004037985A3 Modulation of g protein coupled receptor activity |
| 04/12/2007 | WO2004024874A8 Antibodies that recognize hyperproliferative cells and methods of making and using same |
| 04/12/2007 | WO2004000094A8 Predictive markers in cancer therapy |
| 04/12/2007 | WO2002086079A3 T1r3 a novel taste receptor |
| 04/12/2007 | US20070083941 Rat TRPM7 polynucleotide and encoded protein |
| 04/12/2007 | US20070083336 Method for determining the resolution of blood glucose |
| 04/12/2007 | US20070083333 Modeling of systemic inflammatory response to infection |
| 04/12/2007 | US20070083037 Monkey npy y4 receptor and method of evaluating compound |
| 04/12/2007 | US20070082955 Novel target protein of anticancer agent and novel anticancer agent (spnal) corresponding thereto |
| 04/12/2007 | US20070082849 Angiogenic peptides and uses thereof |
| 04/12/2007 | US20070082848 VEGF-C or VEGF-D materials and methods for treatment of neuropathologies |
| 04/12/2007 | US20070082847 Variants of vascular endothelial cell growth factor, their uses, and processes for their production |
| 04/12/2007 | US20070082412 for the manipulation of colloidal particulates and biomolecules at the interface between an insulating electrode such as silicon oxide and an electrolyte solution; for fabrication of surface-mounted optical components; drug screening |
| 04/12/2007 | US20070082411 Detection and identification of biological materials using functionalized quantum dots |
| 04/12/2007 | US20070082410 Stabilization of cardiac troponin |
| 04/12/2007 | US20070082407 Optical determination and reporting of hydrocarbon properties |
| 04/12/2007 | US20070082406 Method for determining the concentration of acrylic acid-c1-c8-ester in combustible gas |
| 04/12/2007 | US20070082405 Method for determining chlorine demand in water |
| 04/12/2007 | US20070082404 Method of Measuring Fluoride in Fluxes Using the Fluoride Ion-Selective Electrode |
| 04/12/2007 | US20070082403 Reagents for highly specific detection of peroxynitrite |
| 04/12/2007 | US20070082402 Device and process for the quantitative evaluation of the polypeptides and markers contained in a sample of body fluid for recognizing pathological conditions |
| 04/12/2007 | US20070082382 Development of human monoclonal antibodies and uses thereof |
| 04/12/2007 | US20070082377 Cytotoxicity assays |
| 04/12/2007 | US20070082371 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 04/12/2007 | US20070082370 formed of polycarbonate and polyethylene terephthalate; does not damage erythrocytes |
| 04/12/2007 | US20070082369 Method for production and use of mite group 1 proteins |
| 04/12/2007 | US20070082368 Human cell clones useful for functional analyses of the biological activity of an endogeneous urotensin II receptor and uses thereof |
| 04/12/2007 | US20070082367 Methods of purifying anti a beta antibodies |
| 04/12/2007 | US20070082366 Alzheimer's disease-specific alterations of the ERK1/ERK2 phosphorylation ratio |
| 04/12/2007 | US20070082365 Protein scaffolds for antibody mimics and other binding proteins |
| 04/12/2007 | US20070082364 Antibody and use thereof |
| 04/12/2007 | US20070082363 Using cardiovascular disorder plasma polypeptides (CPPs) as evaluative tools in detection coronary artery disease |
| 04/12/2007 | US20070082362 Modified soluble t cell receptor |
| 04/12/2007 | US20070082361 DNA and proteins or peptides specific of bacteria of the Neisseria meningitidis species, methods for obtaining them and biological applications thereof |
| 04/12/2007 | US20070082353 Genetic marker selection program for genetic diagnosis, apparatus and system for executing the same, and genetic diagnosis system |
| 04/12/2007 | US20070082346 Homogeneous detection method |
| 04/12/2007 | US20070082341 Human phospholipases |
| 04/12/2007 | US20070082339 Methods and compositions for screening for HDAC inhibitory activity |
| 04/12/2007 | US20070082336 Methods for protein labeling based on acyl carrier protein |
| 04/12/2007 | US20070082335 Methods and compositions for treatment of viral infections based on tsg101-vps28 interaction |
| 04/12/2007 | US20070082334 Nucleotide and protein sequence of mammastatin and methods of use |
| 04/12/2007 | US20070082332 Molecular cardiotoxicology modeling |
| 04/12/2007 | US20070082330 Providing a plurality of icosahedral phage displaying different compounds; andcontacting the plurality of icosahedral phage with the cell, identifying at least one icosahedral phage displaying a compound that is transported into or through the cell |
| 04/12/2007 | US20070082327 Cellular phenotype |
| 04/12/2007 | US20070082019 Photocrosslinked hydrogel surface coatings |
| 04/12/2007 | US20070082003 Method for selecting and producing vaccine components and vaccines based thereon |
| 04/12/2007 | US20070081997 Diagnostics and therapeutics for diseases associated with kallikrein 9 (klk9) |